Recombinant human interferon α2b for injection

Recombinant human interferon α2b, human serum albumin.

It can be used to treat acute and chronic viral hepatitis (type B, type C, etc.), genital warts, hairy cell leukemia, chronic myeloid leukemia, lymphoma, AIDS-related Kaposi's sarcoma, malignant melanoma and other diseases.

This product can be injected intramuscularly, subcutaneously and intralesionally. Use after completely dissolving with 1-2ml sterile water for injection. 1. Chronic hepatitis B: The recommended dose is 3-5 million international units (IU) each time, injected once a day or every other day, 3-6 months as a course of treatment, and the doctor can adjust the dose according to the specific situation of the patient. 2. Chronic hepatitis C: The recommended dose is 3-5 million international units (IU) each time, injected once a day or every other day, 3-6 months as a course of treatment, and the doctor can adjust the dose according to the specific situation of the patient. 3. Genital warts: The recommended dose is 1-3 million international units (IU) each time, injected three times every other day per week, 1-2 months as a course of treatment. 4. Hairy cell leukemia: The recommended dose is 3 million international units (IU) each time, injected three times every other day per week, and the doctor can adjust the dose according to the specific situation of the patient. Usually, the effect is shown after 1-2 months of treatment, and intermittent treatment can be carried out afterwards to achieve long-term remission of the disease. 5. Chronic myeloid leukemia: The recommended dose is 3-9 million international units (IU) injected daily for three months. The doctor can adjust the dose according to the patient's specific situation. After the blood picture is relieved, maintenance treatment can be carried out, with injections every other day. Cytogenetic indicators can be relieved after 9-10 months.

Patients with a history of allergy to interferon α2b or other ingredients of this preparation, as well as patients with severe liver, kidney and bone marrow dysfunction should not use this product.

Store in dark place at 2-8℃.

5 million IU/vial

30 months.

Harbin Pharmaceutical Group Bioengineering Co., Ltd.

• Founded in:

  1995-02-20

• Address:

  No. 99, Zhuhai Road, Limin Development Zone, Hulan District, Harbin

• Tax NO.:

  91230111128024298B

• Registered Funds:

  186.0655 million yuan

• Website:

  Log in to view

• Email:

  Log in to view